| Balance Sheets | 2026-03-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 35,719 | |||
| Short-term marketable securities | 140,030 | |||
| Prepaid expenses and other current assets | 9,352 | |||
| Total current assets | 185,101 | |||
| Property, plant and equipment, gross | 21,663 | |||
| Less accumulated depreciation | 15,107 | |||
| Property and equipment, net | 6,556 | |||
| Right-of-use assets | 17,920 | |||
| Goodwill | 14,072 | |||
| Intangible asset | 160 | |||
| Long-term marketable securities | 0 | |||
| Other non-current assets | 5,261 | |||
| Total assets | 229,070 | |||
| Accounts payable | 8,219 | |||
| Accrued expenses and other current liabilities | 8,618 | |||
| Lease liabilities, current | 5,374 | |||
| Total current liabilities | 22,211 | |||
| Contingent consideration and warrant liability | 6,242 | |||
| Lease liabilities, non-current | 20,753 | |||
| Total liabilities | 49,206 | |||
| Convertible preferred stock-Series APreferred Stock | 216,503 | |||
| Convertible preferred stock-Series BPreferred Stock | 167,765 | |||
| Convertible preferred stock-Series CPreferred Stock | 123,259 | |||
| Convertible preferred stock-Series DPreferred Stock | 196,031 | |||
| Additional paid-in capital | 82,854 | |||
| Accumulated deficit | -606,401 | |||
| Accumulated other comprehensive income (loss) | -147 | |||
| Total stockholders deficit | -523,694 | |||
| Total liabilities, convertible preferred stock, and stockholders deficit | 229,070 | |||
Odyssey Therapeutics, Inc. (ODTX)
Odyssey Therapeutics, Inc. (ODTX)